BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38426765)

  • 1. Human Vγ9Vδ2 T cells exhibit antifungal activity against
    Koga S; Takazono T; Namie H; Okuno D; Ito Y; Nakada N; Hirayama T; Takeda K; Ide S; Iwanaga N; Tashiro M; Sakamoto N; Watanabe A; Izumikawa K; Yanagihara K; Tanaka Y; Mukae H
    Microbiol Spectr; 2024 Apr; 12(4):e0361423. PubMed ID: 38426765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine.
    Dos Reis TF; Horta MAC; Colabardini AC; Fernandes CM; Silva LP; Bastos RW; Fonseca MVL; Wang F; Martins C; Rodrigues ML; Silva Pereira C; Del Poeta M; Wong KH; Goldman GH
    mBio; 2021 Aug; 12(4):e0145821. PubMed ID: 34372704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting
    Kumaresan PR; Wurster S; Bavisi K; da Silva TA; Hauser P; Kinnitt J; Albert ND; Bharadwaj U; Neelapu S; Kontoyiannis DP
    mBio; 2024 Apr; 15(4):e0341323. PubMed ID: 38415653
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Colley T; Alanio A; Kelly SL; Sehra G; Kizawa Y; Warrilow AGS; Parker JE; Kelly DE; Kimura G; Anderson-Dring L; Nakaoki T; Sunose M; Onions S; Crepin D; Lagasse F; Crittall M; Shannon J; Cooke M; Bretagne S; King-Underwood J; Murray J; Ito K; Strong P; Rapeport G
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the epidemiological landscape of invasive mould infections and disease.
    Lass-Flörl C; Cuenca-Estrella M
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i5-i11. PubMed ID: 28355462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
    Snelders E; Melchers WJ; Verweij PE
    Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, Drug Susceptibility, and Clinical Risk Factors in Patients With Invasive Aspergillosis.
    Wang Y; Zhang L; Zhou L; Zhang M; Xu Y
    Front Public Health; 2022; 10():835092. PubMed ID: 35493371
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Colley T; Sehra G; Chowdhary A; Alanio A; Kelly SL; Kizawa Y; Armstrong-James D; Fisher MC; Warrilow AGS; Parker JE; Kelly DE; Kimura G; Nishimoto Y; Sunose M; Onions S; Crepin D; Lagasse F; Crittall M; Shannon J; McConville M; King-Underwood J; Naylor A; Bretagne S; Murray J; Ito K; Strong P; Rapeport G
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus.
    Lamoth F; Juvvadi PR; Steinbach WJ
    Crit Rev Microbiol; 2016; 42(2):310-21. PubMed ID: 25243616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus.
    Torres HA; Rivero GA; Lewis RE; Hachem R; Raad II; Kontoyiannis DP
    Diagn Microbiol Infect Dis; 2003 May; 46(1):25-8. PubMed ID: 12742315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013.
    van Paassen J; Russcher A; In 't Veld-van Wingerden AW; Verweij PE; Kuijper EJ
    Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27541498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung.
    Seyedmousavi S; Davis MJ; Sugui JA; Pinkhasov T; Moyer S; Salazar AM; Chang YC; Kwon-Chung KJ
    mBio; 2018 Mar; 9(2):. PubMed ID: 29588403
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Shaheen SK; Juvvadi PR; Allen J; Shwab EK; Cole DC; Asfaw YG; Kapoor M; Shaw KJ; Steinbach WJ
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0068221. PubMed ID: 34310205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit.
    Peláez T; Muñoz P; Guinea J; Valerio M; Giannella M; Klaassen CH; Bouza E
    Clin Infect Dis; 2012 Feb; 54(3):e24-31. PubMed ID: 22247307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pathogenesis of
    Gu X; Hua YH; Zhang YD; Bao DI; Lv J; Hu HF
    Pol J Microbiol; 2021 Mar; 70(1):3-11. PubMed ID: 33815522
    [No Abstract]   [Full Text] [Related]  

  • 16. The Aspergillus fumigatus Mismatch Repair
    Dos Reis TF; Silva LP; de Castro PA; do Carmo RA; Marini MM; da Silveira JF; Ferreira BH; Rodrigues F; Lind AL; Rokas A; Goldman GH
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31391280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Impact of Polymerase Chain Reaction-Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study.
    Huygens S; Dunbar A; Buil JB; Klaassen CHW; Verweij PE; van Dijk K; de Jonge N; Janssen JJWM; van der Velden WJFM; Biemond BJ; Bart A; Bruns AHW; Haas PA; Demandt AMP; Oudhuis G; von dem Borne P; van der Beek MT; Klein SK; Godschalk P; Span LFR; Postma DF; Kampinga GA; Maertens J; Lagrou K; Mercier T; Moors I; Boelens J; Selleslag D; Reynders M; Zandijk W; Doorduijn JK; Cornelissen JJ; Schauwvlieghe AFAD; Rijnders BJA
    Clin Infect Dis; 2023 Jul; 77(1):38-45. PubMed ID: 36905147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
    van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
    Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy.
    Ambati S; Ferarro AR; Kang SE; Lin J; Lin X; Momany M; Lewis ZA; Meagher RB
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760610
    [No Abstract]   [Full Text] [Related]  

  • 20. The Caspofungin Paradoxical Effect is a Tolerant "Eagle Effect" in the Filamentous Fungal Pathogen
    Valero C; Colabardini AC; de Castro PA; Amich J; Bromley MJ; Goldman GH
    mBio; 2022 Jun; 13(3):e0044722. PubMed ID: 35420487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.